To obtain a medicinal composition comprising an effective ingredient selected from the group consisting of omeprazole and a physiologically acceptable salt thereof as an active ingredient, having excellent preservation stability and achieving rapid elution of the effective ingredient in the environment at pH≥5, preferably pH≥6.
A core part is protected from an enteric film by forming an interlayer provided between the core part containing the effective ingredient and the enteric film as a substantially water-insoluble and water-permeable layer using a water-insoluble polymer. Water permeated through the interlayer is absorbed on the core part by formulating a substance swelling by absorbing the water in the core part. Cracks and/or cleavages are then rapidly produced in the interlayer by swelling of the core part. As a result, the effective ingredient can be eluted from the core part at an ultrahigh rate.
JP2016098190 | ORAL PHARMACEUTICAL COMPOSITION CONTAINING TELMISARTAN |
WO/2000/018835 | MODIFIED STARCH FILM COMPOSITIONS |
WO/2008/124081 | RAPID DISSOLUTION OF COMBINATION PRODUCTS |
JP2002522472A | 2002-07-23 | |||
JPH01290628A | 1989-11-22 | |||
JP2001526213A | 2001-12-18 | |||
JP2001055322A | 2001-02-27 | |||
JPS62169727A | 1987-07-25 | |||
JP2000516637A | 2000-12-12 | |||
JPH05255088A | 1993-10-05 | |||
JP2002212062A | 2002-07-31 | |||
JPS6230709A | 1987-02-09 | |||
JPS5867616A | 1983-04-22 | |||
JP2001270827A | 2001-10-02 | |||
JP2002154948A | 2002-05-28 |
WO2003000263A1 | 2003-01-03 |
Next Patent: METHOD FOR SYNTHESIZING 3-CHLORO-5-NITROTOLUENE